The firms said they turned to the business consultants for advice ranging “from operational integration through to ways of working.”        

A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.        

“I encouraged those coming up to focus on building grit as part of their toolboxes. … Associates in 2024 are being called upon to demonstrate that grit from the jump,” writes Kate Reder Sheikh.        

This suit was surfaced by Law.com Radar, ALM’s source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.        

The U.S.’ lead with generative AI models and the EU’s broad regulation of the technology may eventually set the stage for two potentially different AI markets.        

The plaintiffs allege that Change Health said that “‘electronic payment functionality will be available for connection beginning March 15,’” and that they would “‘reestablish connectivity to [their] claims network and software on March 18, restoring service through the week.’” However, those promises have gone unfulfilled, according to the plaintiffs.        

It’s one of the first times a theory of reverse redlining, an illegal and discriminatory practice of targeting a particular neighborhood or group for credit on unfair terms, has been put to the test in the educational sector, Lila Miller of Relman Colfax told Law.com. Typically, reverse redlining is often seen in connection with home […]

“Brett Gerry is an impressive man, with a gold plated resume. He is going to need it. He has the toughest repair job in the entire legal industry right now,” legal department consultant Jason Winmill said.        

“Focus on the business of the firm, learn its work and the personalities of those that are doing the work.”        

Lawyers in high-profile trials have noticed more jurors in the deliberations holding steadfast to their beliefs, regardless of the evidence. That’s causing mistrials, like the one this month involving Johnson & Johnson in a Florida talc trial.